SG10201505540SA - Process for preparing antiviral compounds - Google Patents
Process for preparing antiviral compoundsInfo
- Publication number
- SG10201505540SA SG10201505540SA SG10201505540SA SG10201505540SA SG10201505540SA SG 10201505540S A SG10201505540S A SG 10201505540SA SG 10201505540S A SG10201505540S A SG 10201505540SA SG 10201505540S A SG10201505540S A SG 10201505540SA SG 10201505540S A SG10201505540S A SG 10201505540SA
- Authority
- SG
- Singapore
- Prior art keywords
- antiviral compounds
- preparing antiviral
- preparing
- compounds
- antiviral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2419—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member
- B01J31/2423—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member comprising aliphatic or saturated rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/30—Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
- B01J2231/34—Other additions, e.g. Monsanto-type carbonylations, addition to 1,2-C=X or 1,2-C-X triplebonds, additions to 1,4-C=C-C=X or 1,4-C=-C-X triple bonds with X, e.g. O, S, NH/N
- B01J2231/341—1,2-additions, e.g. aldol or Knoevenagel condensations
- B01J2231/342—Aldol type reactions, i.e. nucleophilic addition of C-H acidic compounds, their R3Si- or metal complex analogues, to aldehydes or ketones
- B01J2231/344—Boronation, e.g. by adding R-B(OR)2
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4205—C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
- B01J2231/4211—Suzuki-type, i.e. RY + R'B(OR)2, in which R, R' are optionally substituted alkyl, alkenyl, aryl, acyl and Y is the leaving group
- B01J2231/4227—Suzuki-type, i.e. RY + R'B(OR)2, in which R, R' are optionally substituted alkyl, alkenyl, aryl, acyl and Y is the leaving group with Y= Cl
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4277—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues
- B01J2231/4283—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues using N nucleophiles, e.g. Buchwald-Hartwig amination
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4277—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues
- B01J2231/4288—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues using O nucleophiles, e.g. alcohols, carboxylates, esters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4277—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues
- B01J2231/4294—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues using S nucleophiles, e.g. thiols
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/824—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36529310P | 2010-07-16 | 2010-07-16 | |
US201161444475P | 2011-02-18 | 2011-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201505540SA true SG10201505540SA (en) | 2015-08-28 |
Family
ID=45467152
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201505540SA SG10201505540SA (en) | 2010-07-16 | 2011-07-15 | Process for preparing antiviral compounds |
SG2013003579A SG187102A1 (en) | 2010-07-16 | 2011-07-15 | Process for preparing antiviral compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2013003579A SG187102A1 (en) | 2010-07-16 | 2011-07-15 | Process for preparing antiviral compounds |
Country Status (23)
Country | Link |
---|---|
US (1) | US8895737B2 (en) |
EP (3) | EP3415504A1 (en) |
JP (2) | JP5819959B2 (en) |
KR (1) | KR101893751B1 (en) |
CN (2) | CN105622525B (en) |
AU (1) | AU2011278927B2 (en) |
BR (1) | BR112013001132A2 (en) |
CA (1) | CA2805748A1 (en) |
CL (2) | CL2013000159A1 (en) |
CO (1) | CO6670583A2 (en) |
CR (2) | CR20180412A (en) |
DO (1) | DOP2013000017A (en) |
EA (2) | EA201790723A1 (en) |
EC (1) | ECSP13012438A (en) |
GT (1) | GT201300021A (en) |
IL (1) | IL224222A (en) |
MX (2) | MX2013000623A (en) |
MY (1) | MY167881A (en) |
NZ (2) | NZ605767A (en) |
PE (1) | PE20131086A1 (en) |
SG (2) | SG10201505540SA (en) |
UA (1) | UA115025C2 (en) |
WO (1) | WO2012009699A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8895737B2 (en) * | 2010-07-16 | 2014-11-25 | Shashank Shekhar | Process for preparing antiviral compounds |
NZ704603A (en) | 2010-07-16 | 2016-06-24 | Abbvie Inc | Phosphine ligands for catalytic reactions |
US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
SG10202010626PA (en) * | 2011-03-31 | 2020-11-27 | Schaefer Konstanze | Perfluorinated compounds for the non-viral transfer of nucleic acids |
WO2014031791A1 (en) * | 2012-08-21 | 2014-02-27 | Abbvie Inc. | Process for preparing antiviral compounds |
WO2015038596A1 (en) | 2013-09-11 | 2015-03-19 | Emory University | Nucleotide and nucleoside compositions and uses related thereto |
WO2016054240A1 (en) | 2014-09-30 | 2016-04-07 | Sean Dalziel | Fixed dose combinations for the treatment of viral diseases |
WO2016105547A1 (en) | 2014-12-24 | 2016-06-30 | Concert Pharmaceuticals, Inc. | Deuterated dasabuvir |
US11192914B2 (en) | 2016-04-28 | 2021-12-07 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
WO2017202207A1 (en) * | 2016-05-27 | 2017-11-30 | 深圳市塔吉瑞生物医药有限公司 | Substituted naphthalene ring compound, pharmaceutical composition, and application thereof |
CN110201714B (en) * | 2019-07-04 | 2022-07-29 | 蚌埠学院 | Synthesis method and catalyst of dihydropyrimidinone compound |
CN110669006A (en) * | 2019-10-22 | 2020-01-10 | 中国科学技术大学 | Indeno isoquinoline compounds and preparation method thereof |
CN112735799B (en) * | 2020-12-10 | 2022-12-20 | 华东理工大学 | Novel magnetic material and preparation method thereof |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4239888A (en) | 1974-11-04 | 1980-12-16 | Pfizer Inc. | 1-Phenyluracils |
JPS60243017A (en) | 1984-05-16 | 1985-12-03 | Kyowa Hakko Kogyo Co Ltd | Antispasmodic composition |
US4731472A (en) | 1986-03-03 | 1988-03-15 | Merck & Co., Inc. | (5,6-dichloro-3-oxo-9A-propyl-2,3,9,9A-tetrahydrofluoren-7-yl)alkanoic acids and alkanimidamides |
US4958023A (en) | 1988-09-19 | 1990-09-18 | American Home Products Corporation | 2-pyridinecarbothioamides, processes for preparation thereof and pharmaceutical compositions comprising the same |
US4873238A (en) | 1988-09-19 | 1989-10-10 | American Home Products Corporation | 2-Pyridinecarbothioamides and pharmaceutical compositions comprising the same |
US5084084A (en) | 1989-07-14 | 1992-01-28 | Nissan Chemical Industries Ltd. | Uracil derivatives and herbicides containing the same as active ingredient |
AU627906B2 (en) | 1989-07-14 | 1992-09-03 | Nissan Chemical Industries Ltd. | Uracil derivatives and herbicides containing the same as active ingredient |
ATE169915T1 (en) | 1990-02-15 | 1998-09-15 | Takeda Chemical Industries Ltd | PYRIMIDINEDIONE DERIVATIVES, THEIR PREPARATION AND USE |
NL9001075A (en) | 1990-05-04 | 1991-12-02 | Duphar Int Res | |
WO1992009545A2 (en) | 1990-11-21 | 1992-06-11 | Massachusetts Institute Of Technology | New methods for the catalytic reduction of organic substrates |
US5489682A (en) | 1990-11-21 | 1996-02-06 | Massachusetts Institute Of Technology | Catalytic asymmetric reduction of enamines |
ATE165361T1 (en) | 1992-01-31 | 1998-05-15 | Hoffmann La Roche | DIPHOSPHINE LIGANDS |
JPH05213755A (en) | 1992-02-07 | 1993-08-24 | Nikko Kyodo Co Ltd | Therapeutic agent for hepatopathy |
JP3345476B2 (en) | 1993-05-18 | 2002-11-18 | 株式会社東芝 | Organic nonlinear optical material |
IT1264813B1 (en) | 1993-07-28 | 1996-10-10 | Oxon Italia Spa | PROCESS FOR THE PREPARATION OF ALCANSOLPHONAMIDES |
DK0647648T3 (en) | 1993-10-08 | 1999-09-27 | Hoffmann La Roche | Optically active phosphorus compounds |
DE19528305A1 (en) | 1995-08-02 | 1997-02-06 | Bayer Ag | Substituted phenyluracile |
WO1997018179A1 (en) | 1995-11-14 | 1997-05-22 | Massachusetts Institute Of Technology | Replacement solvents for use in chemical synthesis |
US6031105A (en) | 1996-04-09 | 2000-02-29 | Pfizer Inc | Substituted pyridines |
US5847166A (en) | 1996-10-10 | 1998-12-08 | Massachusetts Institute Of Technology | Synthesis of aryl ethers |
US20050065353A1 (en) | 1996-12-03 | 2005-03-24 | Smith Amos B. | Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
US6242616B1 (en) | 1996-12-03 | 2001-06-05 | The Trustees Of The University Of Pennsylvania | Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
US6870058B2 (en) | 1996-12-03 | 2005-03-22 | The Trustees Of The University Of Pennsylvania | Compounds which mimic the chemical and biological properties of discodermolide |
US5789605A (en) | 1996-12-03 | 1998-08-04 | Trustees Of The University Of Pennsylvania | Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof |
US6096904A (en) | 1996-12-03 | 2000-08-01 | The Trustees Of The University Of Pennsylvania | Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
US6323366B1 (en) | 1997-07-29 | 2001-11-27 | Massachusetts Institute Of Technology | Arylamine synthesis |
WO1999018057A1 (en) | 1997-10-06 | 1999-04-15 | Massachusetts Institute Of Technology | Preparation of diaryl ether by condensation reactions |
US6867310B1 (en) | 1997-11-20 | 2005-03-15 | Massachusetts Institute Of Technology | Arylation and vinylation of activated carbons |
WO1999028290A1 (en) | 1997-12-03 | 1999-06-10 | Massachusetts Institute Of Technology | Synthesis of oligoarylamines, and uses and reagents related thereto |
DE69904448T2 (en) | 1998-02-26 | 2003-10-23 | Massachusetts Inst Technology | METAL-CATALYZED ARYLATIONS AND VINYLATIONS OF HYDRAZINES, HYDRAZONES, HYDROXYLAMINES AND OXIMES |
JP5035813B2 (en) | 1998-07-10 | 2012-09-26 | マサチューセッツ インスティテュート オブ テクノロジー | Ligands for metals and improved metal catalyst processes based on them |
US6307087B1 (en) | 1998-07-10 | 2001-10-23 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
US6395916B1 (en) | 1998-07-10 | 2002-05-28 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
US7223879B2 (en) | 1998-07-10 | 2007-05-29 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
DE19920847A1 (en) | 1999-05-06 | 2000-11-09 | Clariant Gmbh | Pd and Ni complexes of biphenyl-2-ylphosphanes and their application in catalytic C, C, N and C, O couplings |
WO2001019761A2 (en) | 1999-09-15 | 2001-03-22 | Massachusetts Institute Of Technology | Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems |
WO2001038337A2 (en) | 1999-11-24 | 2001-05-31 | Massachusetts Institute Of Technology | Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries |
US6380387B1 (en) | 1999-12-06 | 2002-04-30 | Hoffmann-La Roche Inc. | 4-Pyrimidinyl-n-acyl-l phenylalanines |
PL207160B1 (en) | 1999-12-06 | 2010-11-30 | Hoffmann La Roche | 4−pyrimidinyl−n−acyl−l−phenylalanines |
IL167954A (en) | 2000-02-04 | 2007-10-31 | Sumitomo Chemical Co | Pyrimidine derivatives |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
US6624159B2 (en) | 2000-07-12 | 2003-09-23 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
DK1390340T3 (en) | 2001-04-24 | 2017-05-15 | Massachusetts Inst Technology | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
CA2446716A1 (en) * | 2001-06-05 | 2002-12-12 | Eli Lilly And Company | Sulfonamide derivatives |
CA2456553A1 (en) | 2001-08-07 | 2003-02-20 | Amos B. Smith, Iii | Compounds which mimic the chemical and biological properties of discodermolide |
DE10162700A1 (en) * | 2001-12-19 | 2003-07-03 | Merck Patent Gmbh | Dioxathianone |
JP2005530681A (en) | 2001-12-20 | 2005-10-13 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Pyridoquinoxaline antiviral agent |
WO2003066570A1 (en) | 2002-02-04 | 2003-08-14 | Massachusetts Institute Of Technology | Transition-metal-catalyzed carbon-nitrogen bond-forming methods using carbene ligands |
ITMI20020415A1 (en) | 2002-03-01 | 2003-09-01 | Chemi Spa | METAL CATALYSTS FOR CHEMO-REGIO-STEREO-SELECTIVE REACTION PRECURSORS |
AU2003257062A1 (en) | 2002-08-02 | 2004-02-23 | Massachusetts Institute Of Technology | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
US20040110802A1 (en) | 2002-08-23 | 2004-06-10 | Atli Thorarensen | Antibacterial benzoic acid derivatives |
US20050113450A1 (en) | 2002-08-23 | 2005-05-26 | Atli Thorarensen | Antibacterial agents |
AU2003265382A1 (en) | 2002-08-23 | 2004-03-11 | Pharmacia & Upjohn Company Llc | Antibacterial benzoic acid derivatives |
US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
US20040097492A1 (en) * | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
CA2509522C (en) | 2002-12-09 | 2013-05-07 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
US7163937B2 (en) | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
RU2006123559A (en) | 2003-12-04 | 2008-01-10 | Уайт (Us) | BIARILSULPHONAMIDES AS MMP INHIBITORS |
US7507832B2 (en) | 2003-12-22 | 2009-03-24 | Eli Lilly And Company | Triazole PPAR modulators |
AU2005303492A1 (en) | 2004-11-10 | 2006-05-18 | Pfizer Inc. | Substituted N-sulfonylaminobenzyl-2-phenoxy acetamide compounds |
SE0403006D0 (en) | 2004-12-09 | 2004-12-09 | Biovitrum Ab | New compounds |
GB0427403D0 (en) | 2004-12-15 | 2005-01-19 | Astrazeneca Ab | Novel compounds I |
WO2006066174A1 (en) | 2004-12-17 | 2006-06-22 | Eli Lilly And Company | Thiazolopyridinone derivates as mch receptor antagonists |
WO2006074315A2 (en) | 2005-01-10 | 2006-07-13 | Massachusetts Institute Of Technology | Transition-metal-catalyzed carbon-nitrogen and carbon-carbon bond-forming reactions |
EP1858865B1 (en) | 2005-03-10 | 2009-09-16 | Pfizer Inc. | Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds |
EA200701745A1 (en) | 2005-03-17 | 2008-06-30 | Пфайзер, Инк. | CYCLOPROPANKARCARBOXAMID DERIVATIVES |
WO2007133637A2 (en) | 2006-05-10 | 2007-11-22 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
GB0713686D0 (en) | 2007-07-13 | 2007-08-22 | Addex Pharmaceuticals Sa | New compounds 2 |
US8258131B2 (en) | 2007-08-01 | 2012-09-04 | Mitsubishi Tanabe Pharma Corporation | Fused bicyclic compound |
TWI437994B (en) * | 2007-09-17 | 2014-05-21 | Abbvie Bahamas Ltd | Anti-infective agents and uses thereof |
CN101842360B (en) | 2007-09-17 | 2014-12-17 | 艾伯维巴哈马有限公司 | Anti-infective pyrimidines and uses thereof |
DK2203430T3 (en) | 2007-09-17 | 2011-09-26 | Abbott Lab | N-phenyl-dioxo-hydropyrimidines useful as inhibitors of hepatitis C virus (HCV) |
EP2231680B1 (en) | 2007-12-12 | 2018-03-28 | Massachusetts Institute of Technology | Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof |
AU2009273327A1 (en) | 2008-07-23 | 2010-01-28 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
EP2184273A1 (en) | 2008-11-05 | 2010-05-12 | Bayer CropScience AG | Halogen substituted compounds as pesticides |
JP5326510B2 (en) | 2008-11-11 | 2013-10-30 | セントラル硝子株式会社 | Process for producing α-substituted esters |
WO2010111348A1 (en) | 2009-03-24 | 2010-09-30 | Abbott Laboratories | Process for preparing antiviral compound |
BRPI1011744A2 (en) | 2009-06-24 | 2016-03-22 | Hoffmann La Roche | heterocyclic antiviral compound. |
US20110005533A1 (en) | 2009-07-07 | 2011-01-13 | Evans Douglas J | Mold For a Smoking Device |
US20110015401A1 (en) | 2009-07-13 | 2011-01-20 | Massachusetts Institute Of Technology | Metal-Catalyzed Carbon-Fluorine Bond Formation |
WO2011008618A1 (en) | 2009-07-13 | 2011-01-20 | National University Of Singapore | Metal-catalyzed carbon-fluorine bond formation |
AR079170A1 (en) | 2009-12-10 | 2011-12-28 | Lilly Co Eli | COMPOSITE OF CICLOPROPIL-BENZAMIDA-IMIDAZO-BENZAZEPINA INHIBITOR OF DIACIL-GLICEROL ACILTRANSFERASA, SALT OF THE SAME, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE TO PREPARE A USEFUL MEDICATION FOR THE TREATMENT OF INTEREST OR COMPENSATION |
AU2010327936B2 (en) | 2009-12-11 | 2015-08-20 | Nono Inc. | Agents and methods for treating ischemic and other diseases |
US20130022629A1 (en) | 2010-01-04 | 2013-01-24 | Sharpe Arlene H | Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof |
FR2958289B1 (en) | 2010-03-30 | 2012-06-15 | Sanofi Aventis | PROCESS FOR THE PREPARATION OF 3-KETO-BENZOFURAN DERIVATIVES |
US20130231360A1 (en) | 2010-04-22 | 2013-09-05 | The Brigham And Women S Hospital, Inc. | Beta-Carbolines as Inhibitors of Haspin and DYRK Kinases |
EP2571876B1 (en) | 2010-05-21 | 2016-09-07 | Merck Sharp & Dohme Corp. | Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
NZ704603A (en) | 2010-07-16 | 2016-06-24 | Abbvie Inc | Phosphine ligands for catalytic reactions |
US8895737B2 (en) * | 2010-07-16 | 2014-11-25 | Shashank Shekhar | Process for preparing antiviral compounds |
-
2011
- 2011-07-15 US US13/184,440 patent/US8895737B2/en not_active Expired - Fee Related
- 2011-07-15 SG SG10201505540SA patent/SG10201505540SA/en unknown
- 2011-07-15 NZ NZ605767A patent/NZ605767A/en not_active IP Right Cessation
- 2011-07-15 EA EA201790723A patent/EA201790723A1/en unknown
- 2011-07-15 KR KR1020137003947A patent/KR101893751B1/en active IP Right Grant
- 2011-07-15 MX MX2013000623A patent/MX2013000623A/en active IP Right Grant
- 2011-07-15 JP JP2013519865A patent/JP5819959B2/en not_active Expired - Fee Related
- 2011-07-15 CA CA2805748A patent/CA2805748A1/en not_active Abandoned
- 2011-07-15 MY MYPI2013700083A patent/MY167881A/en unknown
- 2011-07-15 AU AU2011278927A patent/AU2011278927B2/en not_active Ceased
- 2011-07-15 UA UAA201301879A patent/UA115025C2/en unknown
- 2011-07-15 PE PE2013000078A patent/PE20131086A1/en not_active Application Discontinuation
- 2011-07-15 CN CN201610048270.9A patent/CN105622525B/en not_active Expired - Fee Related
- 2011-07-15 EP EP18182779.1A patent/EP3415504A1/en not_active Withdrawn
- 2011-07-15 CN CN201180044545.7A patent/CN103097360B/en not_active Expired - Fee Related
- 2011-07-15 EP EP11739236.5A patent/EP2593439B1/en active Active
- 2011-07-15 MX MX2015002113A patent/MX344148B/en unknown
- 2011-07-15 WO PCT/US2011/044283 patent/WO2012009699A2/en active Application Filing
- 2011-07-15 EP EP16158981.7A patent/EP3056486B1/en not_active Not-in-force
- 2011-07-15 CR CR20180412A patent/CR20180412A/en unknown
- 2011-07-15 NZ NZ705225A patent/NZ705225A/en not_active IP Right Cessation
- 2011-07-15 BR BR112013001132A patent/BR112013001132A2/en not_active Application Discontinuation
- 2011-07-15 SG SG2013003579A patent/SG187102A1/en unknown
- 2011-07-15 EA EA201390130A patent/EA028082B1/en not_active IP Right Cessation
-
2013
- 2013-01-14 IL IL224222A patent/IL224222A/en active IP Right Grant
- 2013-01-16 GT GT201300021A patent/GT201300021A/en unknown
- 2013-01-16 CL CL2013000159A patent/CL2013000159A1/en unknown
- 2013-01-16 DO DO2013000017A patent/DOP2013000017A/en unknown
- 2013-02-07 CO CO13025305A patent/CO6670583A2/en unknown
- 2013-02-08 CR CR20130054A patent/CR20130054A/en unknown
- 2013-02-13 EC ECSP13012438 patent/ECSP13012438A/en unknown
-
2015
- 2015-09-29 JP JP2015191211A patent/JP6162191B2/en not_active Expired - Fee Related
-
2016
- 2016-02-19 CL CL2016000382A patent/CL2016000382A1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL252345A0 (en) | Antiviral compounds | |
SG10201505540SA (en) | Process for preparing antiviral compounds | |
HUE056588T2 (en) | Process for preparing polyolefins | |
GB201006753D0 (en) | Process for preparing an immunolobulin composition | |
IL214600A0 (en) | Process for preparing substituted 2-nitrobiphenyls | |
IL222290A0 (en) | Process for preparing aminobenzofuran derivatives | |
IL222191A0 (en) | Process for preparing sulfonamido-benzofuran derivatives | |
IL220357A0 (en) | Process for preparing substituted 1-o-acyl-2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranoses | |
EP2534127A4 (en) | Process for preparing (r)-2-acetamido-n-benzyl-3-methoxy-propionamide | |
IL227872A0 (en) | Process for preparing substituted n-phenylhydroxylamines | |
ZA201207386B (en) | Process for preparing benzoxaboroles | |
EP2605772A4 (en) | Process for preparing aminocyclohexyl ether compounds | |
HK1199454A1 (en) | Antiviral compounds | |
EP2887941A4 (en) | Process for preparing antiviral compounds | |
IL227220A (en) | Process for preparing 3- alkylsulfinylbenzoyl derivatives | |
HK1166798A1 (en) | Process for preparing an antiviral compound | |
ZA201207291B (en) | Process for preparing silicon-containing azodicarbamides | |
GB2488894B (en) | Process for producing V-Coelenterazine compounds | |
HK1204607A1 (en) | Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2- methyl-pentanoic acid compounds 4--5--4--2--2-- | |
PT2454291E (en) | Process for preparing polyolefins | |
EP2619174A4 (en) | Process for preparing l-phenyl-3-dimethylaminopropane derivative | |
RS55138B1 (en) | Process for preparing polyolefins | |
IL223145A0 (en) | Process for preparing dithiine-tetracarboxy-diimides | |
IL224619A (en) | Process for preparing cyclolignans | |
EP2585436A4 (en) | Process for preparing 4-hydroxypyridines |